Occurrence of gastrointestinal adverse events upon GLP-1 receptor agonist initiation with concomitant metformin use: A post hoc analysis of LEADER, STEP 2, SUSTAIN-6, and PIONEER 6
For instance: people with obesity are more likely to develop type 2 diabetes people with obesity are at an increased riskof developing Alzheimers later in life people with type 2 diabetes are also more likely to develop Alzheimers disease Alzheimers disease is associated with insulin resistance in the brain, with some scientists referring to Alzheimers as type 3 diabetes obesity, type 2 diabetes, and Alzheimers all involve inflammation, and GLP-1 agonists have an anti-inflammatory effect studies in animal models of dementiahave shown that GLP-1 agonists can protect rats brains from damage
29 Johnson, N.P., Metformin use in women with polycystic ovary syndrome
COVID-19 patients show significantly low Omega-3 Index (O3I = 4.15%) compared to healthy subjects (O3I = 7.84%)
Epub 2020 Nov 25
The most successful long-term users treat GHK-Cu scalp application as a permanent daily habit like moisturizing or SPF
